These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 15618242)

  • 1. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
    Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
    Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thin glomerular basement membrane disease].
    Frascà GM; Balestra E; Fanciulli E; Freddi P; Mazzucchelli R; Montironi R; D'Arezzo M; Sagripanti S
    G Ital Nefrol; 2008; 25(1):49-56. PubMed ID: 18264918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
    Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
    Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease.
    Ueda T; Nakajima M; Akazawa H; Maruhashi Y; Shimoyama H; Sakagami Y; Takagawa K; Kamitsuji H; Naito I; Sado Y; Yoshioka A
    Nephron; 2002 Oct; 92(2):271-8. PubMed ID: 12218303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin basement membrane disease in patients with familial IgA nephropathy.
    Frascá GM; Soverini L; Gharavi AG; Lifton RP; Canova C; Preda P; Vangelista A; Stefoni S
    J Nephrol; 2004; 17(6):778-85. PubMed ID: 15593051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
    Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
    Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant Alport's syndrome: study of a large Tunisian family.
    Kharrat M; Makni S; Makni K; Kammoun K; Charfeddine K; Azaeiz H; Jarraya F; Ben Hmida M; Gubler MC; Ayadi H; Hachicha J
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):320-5. PubMed ID: 16970251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
    Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
    Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collagen IV (alpha3-alpha4) nephropathy].
    Torra R; Tazón B; Ars E; Ballarín J
    Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally thin glomerular basement membrane and the Goodpasture epitope.
    Pettersson E; Törnroth T; Wieslander J
    Clin Nephrol; 1990 Mar; 33(3):105-9. PubMed ID: 2182229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome.
    Wei G; Zhihong L; Huiping C; Caihong Z; Zhaohong C; Leishi L
    Nephrol Dial Transplant; 2006 Nov; 21(11):3146-54. PubMed ID: 16940319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study for the diagnosis of Alport's syndrome.
    Wongtrakul P; Shayakul C; Parichatikanond P; Suthipinittharm P; Amjaroen C; Kaewkaukul N; Vongirad A; Ongajyooth L
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S171-81. PubMed ID: 17718259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.